Facebook Twitter Instagram
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Facebook Twitter Instagram
    Pharmacognosy Communications
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Pharmacognosy Communications
    retyeyutreu
    Original Article

    Pharmacognostical and Biological Studies of Delonix regia growing in Egypt: HPLC Profiles

    wadmin2By wadmin2July 9, 2018Updated:August 12, 2021No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn WhatsApp Pinterest Email

    Heba A. El-Gizawy1, Ahmed S. Alazzouni2, Alaadin E. El-Haddad1,*
    1Department of Pharmacognosy, Faculty of Pharmacy, October 6 University, Giza, EGYPT.
    2Department of Zoology, Faculty of Science, Helwan University, Cairo, EGYPT.

    Pharmacognosy Communications,2018,8,3,125-131.
    DOI: 10.5530/pc.2018.3.26.
    Published: July 2018
    Type: Original Article

    ABSTRACT

    Background: Delonix regia (Hook.) Raf. (Fabaceae) is an ornamental tree with flamboyant flowers. Objective: to carry out pharmacognostical studies to evaluate the features of different D. regia organs, quantification and HPLC profiling of phenolics and flavonoids of leaf extract, also to evaluate possible hepatoprotective activities of the leaf hydroalcoholic extract and its fractions. Materials and Methods: Total phenolic content (TPC) as gallic acid equivalent /100 g dried extract (GAE/100 g DE), and total flavonoid content (TFC) as catechin equivalent /100 g (CE/100 g DE) of the leaves were carried out using Folin–Ciocalteu’s and aluminum chloride assays, respectively. Hepatoprotective activity was determined against CCl4 induced hepatotoxicity in rats. Results: TPC and TFC were 5.5 g GAE/100 g DE and 53.3 g CE/100 g DE respectively, with identification of 13 flavonoids, and 17 phenolics. Hesperidin was present as the highest flavonoid content (48622.5 mg/100 g DE), followed by quercetrin (711.5 mg/100 g DE), whilst hydroxytyrosol was the major identified phenolic compound (1111.2 mg/100g DE) followed by catechin (1026.1 mg/100 g DE). The ethyl acetate fraction showed significant protection against the elevation in the levels of serum biochemical parameters, normal hepatocytes with minimum fatty changes, portal vain congestion and mild inflammatory cell infiltration around the portal vain comparable to CCl4 group (P< 0.001). The potent and significant hepatoprotective activity of the ethyl acetate fraction may be attributed to its high content of antioxidant phenolic compounds. Thus, the present study may be the first to test the hepatoprotective effect of Delonix regia fractions. Conclusion: This study recommends the use of D. regia as a natural chemopreventive agent against liver damage and liver toxicity caused by chlorinated agents.

    Key words: Delonix regia, Flavonoids, Hepatoprotective, Pharmacognostical, Phenolics.

    Download PDF
    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    About Journal
    About Journal

    Pharmacognosy Communications [Phcog Commn.] is a quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.
    Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
    Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.
    Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.

    © 2025 Pharmacognosy Communications. Maintained by Manuscript TechnoMedia LLP.

    Type above and press Enter to search. Press Esc to cancel.

    Scroll Up